Pharma Pulse: SteinCares Partners to Expand Biosimilar Access in Latin America and Eli Lilly Issues Warning Over Compounded Tirzepatide Safety

Mar 13, 11:00 AM
Headliner
Share
Subscribe

In today’s Pharma Pulse, Eli Lilly issues a safety warning, and SteinCares enters a licensing agreement with Shilpa Biologicals to expand biosimilar access in Latin America.

Share
Subscribe
Next
Pharma Pulse: FDA Expands Secukinumab Approval for Pediatric HS and Pharmacist-Led Testing Bridges Rural Care Gaps
Top episodes
Overcoming Supply Chain Challenges
by Pharma Pulse
Incorporating AI into Commercialization Plans
by Pharma Pulse
The Capabilities of a 3PL Provider
by Pharma Pulse